AVIR insider filings

Atea Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen AVIR transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 3 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Polsky Bruce — Director2—4 legs · 49,976 sh · $203,3936
Lucidi Bruno — Director1—2 legs · 29,360 sh · $116,4104

Recent insider filings — Atea Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2026-11-194Polsky Bruce — DirectorSale (S): 8,750 @ $4.03EDGAR
2026-11-194Lucidi Bruno — DirectorOption exercise (M): 21,628 @ $1.24 · Sale (S): 6,741 @ $4.03 · Option exercise (M): 53,372 @ $1.24 · Sale (S): 22,619 @ $3.94 · Option exercise (M): 21,628 (derivative) @ $0 · Option exercise (M): 53,372 (derivative) @ $0EDGAR
2026-11-184Polsky Bruce — DirectorOption exercise (M): 48,028 @ $1.24 · Sale (S): 14,254 @ $4.27 · Option exercise (M): 8,720 @ $1.24 · Sale (S): 8,720 @ $4.03 · Option exercise (M): 18,252 @ $1.24 · Sale (S): 18,252 @ $3.95 · +3 moreEDGAR
2026-06-234Lucidi Bruno — DirectorOption exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-06-234Berman Howard — DirectorGrant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-06-234Adams Jerome M. — DirectorOption exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-06-234Murphy Polly A. — DirectorOption exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-06-234Polsky Bruce — DirectorOption exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-06-234DUNCAN BARBARA GAYLE — DirectorOption exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-06-234KIRSCH ARTHUR S — DirectorGrant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-06-234BERGER FRANKLIN M — DirectorOption exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0EDGAR
2026-05-214/AMurphy Polly A. — DirectorPurchase (P): 6,100 @ $4.17EDGAR
2026-05-204Murphy Polly A. — DirectorPurchase (P): 6,100 @ $4.17EDGAR
2026-03-134Corcoran Andrea — See RemarksOption exercise (M): 60,000 @ $1.24 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2026-02-034Horga Maria Arantxa — Chief Medical OfficerOption exercise (M): 51,283 · Tax withholding (F): 16,073 @ $4.24 · Option exercise (M): 41,533 (derivative) @ $0 · Option exercise (M): 9,750 (derivative) @ $0 · Grant/award (A): 173,500 (derivative) @ $0EDGAR
2026-02-034Vavricka John — Chief Commercial OfficerOption exercise (M): 42,083 · Tax withholding (F): 11,570 @ $4.24 · Option exercise (M): 33,333 (derivative) @ $0 · Option exercise (M): 8,750 (derivative) @ $0 · Grant/award (A): 119,520 (derivative) @ $0EDGAR
2026-02-034Hammond Janet MJ — Chief Development OfficerOption exercise (M): 58,050 · Tax withholding (F): 14,136 @ $4.24 · Option exercise (M): 46,800 (derivative) @ $0 · Option exercise (M): 11,250 (derivative) @ $0 · Grant/award (A): 177,000 (derivative) @ $0EDGAR
2026-02-034Foster Wayne — EVP, Chief Accounting OfficerOption exercise (M): 41,333 · Tax withholding (F): 12,132 @ $4.24 · Option exercise (M): 33,333 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0 · Grant/award (A): 108,000 (derivative) @ $0EDGAR
2026-02-034Corcoran Andrea — See RemarksOption exercise (M): 54,866 · Tax withholding (F): 16,104 @ $4.24 · Option exercise (M): 44,366 (derivative) @ $0 · Option exercise (M): 10,500 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0EDGAR
2026-02-034Sommadossi Jean-Pierre — President, CEO, and Chairman, DirectorOption exercise (M): 272,983 · Tax withholding (F): 106,093 @ $4.24 · Option exercise (M): 300,000 @ $1.24 · Option exercise (M): 173,466 (derivative) @ $0 · Option exercise (M): 99,517 (derivative) @ $0 · Option exercise (M): 300,000 (derivative) @ $0EDGAR
2025-06-244Adams Jerome M. — DirectorOption exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0EDGAR
2025-06-244Murphy Polly A. — DirectorOption exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0EDGAR
2025-06-244Lucidi Bruno — DirectorOption exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0EDGAR
2025-06-244Berman Howard — DirectorGrant/award (A): 164,800 (derivative) @ $0EDGAR
2025-06-244Polsky Bruce — DirectorOption exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0EDGAR
2025-06-244Duncan Barbara Gayle — DirectorOption exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0EDGAR
2025-06-244BERGER FRANKLIN M — DirectorOption exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0EDGAR
2025-02-244Kirsch Arthur S — DirectorGrant/award (A): 164,800 (derivative) @ $0EDGAR
2025-02-044Hammond Janet MJ — Chief Development OfficerOption exercise (M): 46,800 · Grant/award (A): 11,250 · Tax withholding (F): 14,134 @ $3.06 · Option exercise (M): 46,800 (derivative) @ $0 · Grant/award (A): 11,250 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2025-02-044Vavricka John — Chief Commercial OfficerOption exercise (M): 33,333 · Grant/award (A): 8,750 · Tax withholding (F): 11,517 @ $3.06 · Option exercise (M): 33,333 (derivative) @ $0 · Grant/award (A): 8,750 (derivative) @ $0 · Grant/award (A): 132,800 (derivative) @ $0EDGAR
2025-02-044Horga Maria Arantxa — Chief Medical OfficerOption exercise (M): 41,533 · Grant/award (A): 9,750 · Tax withholding (F): 16,071 @ $3.06 · Option exercise (M): 41,533 (derivative) @ $0 · Grant/award (A): 9,750 (derivative) @ $0 · Grant/award (A): 192,800 (derivative) @ $0EDGAR
2025-02-044Foster Wayne — EVP, Chief Accounting OfficerOption exercise (M): 33,333 · Grant/award (A): 8,000 · Tax withholding (F): 12,062 @ $3.06 · Option exercise (M): 33,333 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 120,100 (derivative) @ $0EDGAR
2025-02-044Corcoran Andrea — See RemarksOption exercise (M): 44,367 · Grant/award (A): 10,500 · Tax withholding (F): 16,102 @ $3.06 · Option exercise (M): 44,367 (derivative) @ $0 · Grant/award (A): 10,500 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2025-02-044Sommadossi Jean-Pierre — President, CEO, and Chairman, DirectorOption exercise (M): 173,467 · Grant/award (A): 99,517 · Tax withholding (F): 88,601 @ $3.06 · Option exercise (M): 173,467 (derivative) @ $0 · Grant/award (A): 99,518 (derivative) @ $0 · Grant/award (A): 440,000 (derivative) @ $0EDGAR
2025-01-174BERGER FRANKLIN M — DirectorPurchase (P): 15,000 @ $3.19 · Purchase (P): 10,000 @ $3.36EDGAR
2025-01-174/ABERGER FRANKLIN M — DirectorPurchase (P): 15,000 @ $3.19 · Purchase (P): 10,000 @ $3.36EDGAR
2024-12-124BERGER FRANKLIN M — DirectorSale (S): 359,606 @ $2.85EDGAR
2024-09-194Sommadossi Jean-Pierre — President, CEO, and Chairman, DirectorSale (S): 33,941 @ $4.05 · Sale (S): 22,187 @ $4.03 · Sale (S): 1,841 @ $4.00EDGAR
2024-06-214Adams Jerome M. — DirectorGrant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0EDGAR
2024-06-214Lucidi Bruno — DirectorGrant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0EDGAR
2024-06-214Murphy Polly A. — DirectorGrant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0EDGAR
2024-06-214Polsky Bruce — DirectorSale (S): 17,544 @ $3.49 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0EDGAR
2024-06-214Duncan Barbara Gayle — DirectorGrant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0EDGAR
2024-06-214BERGER FRANKLIN M — DirectorGrant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0EDGAR
2024-06-184Murphy Polly A. — DirectorOption exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0EDGAR
2024-06-184Lucidi Bruno — DirectorOption exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0EDGAR
2024-06-184Adams Jerome M. — DirectorOption exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0EDGAR
2024-06-184Polsky Bruce — DirectorOption exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0EDGAR
2024-06-184Duncan Barbara Gayle — DirectorOption exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0EDGAR
2024-06-184BERGER FRANKLIN M — DirectorOption exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0EDGAR

Recent 8-K events — Atea Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-098-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-228-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-088-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-208-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AVIR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs